Conventional treatment options for patients diagnosed with solid cancers or autoimmune diseases are often limited or ineffective. Developing alternative treatments for these challenging conditions ...

INTEGRA Biosciences is inviting labs to leave manual pipetting behind and take their first steps into effortless automation with a new Lab Evolution competition for 2026. One forward-thinking ...

QIAGEN uses INTEGRA’s handheld and benchtop electronic liquid handling technologies to expedite and standardize nucleic acid isolation and PCR setup methods in its Genomic Services division. This ...